Autoimmune neurologic disorders in children.
Autoimmune neurologic diseases are of major clinical importance in children. Antibody-mediated diseases of the central nervous system are now increasingly recognized in childhood, where the antibodies bind to cell surface epitopes on neuronal or glial proteins, and the patients demonstrate either focal or more generalized clinical signs depending on the extent of brain regions targeted by the antibodies. The antibodies are directed towards ion channels, receptors, and membrane proteins; and the diseases include limbic encephalitis and N-methyl-d-aspartate receptor-antibody encephalitis, among many others. Additionally there are conditions where the wider immune system is implicated. Neurologic features like seizures, movement disorders, autonomic dysfunction, and sleep disorders, with neuroimaging and electrophysiologic features, may indicate a specific antibody-mediated or immune disorder. Often, phenotypic overlap is observed between these conditions, and phenotypic variation seen in children with the same condition. Nevertheless, many patients benefit from immunotherapy with substantial improvement, although huge efforts are still required to optimize the outcome for many patients. In many patients no antibodies have yet been identified, even though they respond to immunotherapies. Here we describe the known antibodies and associated diseases, discuss conditions that are thought to be immune-mediated but have no known immunologic biomarker, and provide guidelines for the investigation and classification of these disorders.
Children's Neurosciences, Evelina London Children's Hospital at Guy's and St. Thomas' NHS Trust, Kings Health Partners Academic Health Science Centre, London, UK; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK. Electronic address: ming.lim@gstt.nhs.uk.
Ming
M
Lim
Department of Neurology, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA.
Mark
M
Gorman
D001323:Autoantibodies / Q000378:metabolism; D020274:Autoimmune Diseases of the Nervous System / Q000276:immunology / Q000378:metabolism / Q000628:therapy; D002648:Child; D006801:Humans; D010372:Pediatrics; D016194:Receptors, N-Methyl-D-Aspartate / Q000276:immunology
D001323:Autoantibodies; D016194:Receptors, N-Methyl-D-Aspartate
adaptive; childhood; immune-mediated; immunotherapy; innate; pediatric; systemic